Glytylus MP 2mg/500mg/15mg Tablet ER
Marketer
Capsutab Drugs Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glytylus MP 2mg/500mg/15mg Tablet ER
Metformin/Pioglitazone/Sitagliptin extended-release tablets (2mg/500mg/15mg) manage blood glucose in adults with type 2 diabetes. This triple-combination therapy complements diet and exercise to enhance glycemic control. It improves insulin effectiveness, thus reducing blood sugar. Dosage and duration should strictly follow your physician's instructions. Administer with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless the next dose is imminent; avoid doubling doses. Overdosage risks hypoglycemia. Concurrent use with other antidiabetic medications, alcohol, or skipped meals elevates hypoglycemia risk; regular blood glucose monitoring is vital. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Baseline kidney function tests are necessary before therapy begins. Limit alcohol consumption to mitigate potential side effect intensification.
Primary Ingredients of Glytylus MP 2mg/500mg/15mg Tablet ER
No text provided. Please provide the text you wish to be rephrased.
Uses of Glytylus MP 2mg/500mg/15mg Tablet ER
Managing type 2 diabetes
Major Benefits of Glytylus MP 2mg/500mg/15mg Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Glytylus MP 2mg/500mg/15mg Extended-Release tablets should be administered with a meal.
Common Side effects of Glytylus MP 2mg/500mg/15mg Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glytylus MP 2mg/500mg/15mg Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glytylus MP 2mg/500mg/15mg Extended-Release tablet whole; do not chew, crush, or divide it. Administer this medication with a meal.
How Glytylus MP 2mg/500mg/15mg Tablet ER works:
Glytylus MP 2mg/500mg/15mg Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple-drug approach enhances blood sugar management when single or dual medications prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Glytylus MP 2mg/500mg/15mg Tablet ER ingestion poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The extended-release Glytylus MP 2mg/500mg/15mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glytylus MP 2mg/500mg/15mg tablet is likely unsafe for breastfeeding mothers. Preliminary human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Exercise caution when administering Glytylus MP 2mg/500mg/15mg Tablet ER to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician for guidance. Glytylus MP 2mg/500mg/15mg Tablet ER is contraindicated in patients exhibiting severe renal impairment. Close monitoring of renal function is recommended throughout the treatment period.
LiverCAUTION
Patients with liver impairment should use Glytylus MP 2mg/500mg/15mg Extended-Release tablets cautiously, as dose modification may be necessary. Medical advice is recommended. Glytylus MP 2mg/500mg/15mg Extended-Release tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glytylus MP 2mg/500mg/15mg Tablet ER :
Should you forget to take a Glytylus MP 2mg/500mg/15mg Extended-Release Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glytylus MP 2mg/500mg/15mg Tablet ER
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently